Full Press Release Details
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced senior management’s participation in the following investor events in February:
SVB Securities Global Biopharma Virtual Conference Members of Pliant’s senior management team will conduct meetings with the investment community on Tuesday, February 14, 2023, with Keith Cummings, M.D., Pliant’s Chief Financial Officer, and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, participating in a fireside chat on Wednesday, February 15, 2023, at 3:40 p.m. ET.
Citi Biotech C-Suite Fireside Chat Series Bernard Coulie, M.D., Ph.D., Pliant’s President and Chief Executive Officer, and Éric Lefebvre, M.D., Pliant’s Chief Medical Officer, will participate in a fireside chat on Wednesday, February 22, 2023, at 3:00 p.m. ET. This is an invitation-only event for Citi clients and will not be webcast.
Interested parties can access the SVB Securities fireside chat from the Investor Relations’ Events & Presentation page of Pliant’s website with an audio archive available for 30 days from the time it is made available.
About Pliant Therapeutics, Inc.
Investor and Media Contact:
Vice President, Investor Relations and Corporate Communications
Pliant Therapeutics, Inc.